HYPERCALCEMIA IN HOSPITALIZED-PATIENTS - DIAGNOSTIC AND PROGNOSTIC ASPECTS

  • 1 January 1981
    • journal article
    • research article
    • Vol. 111  (51) , 2017-2023
Abstract
Over a period of 6 1/2 yr hypercalcemia was diagnosed in 86 patients. In 55.8% of cases a malignant tumor was the cause of the elevated Ca levels, and in 22.1% of cases primary hyperparathyroidism (p.Hp.) was diagnosed. In the remaining 19 patients hypercalcemia was related to renal insufficiency (5 patients), vitamin-D intoxication (4) and thiazide therapy (3), while other, rarer causes were identified in 7 cases. As expected, bronchial and breast carcinomas were most frequent (52%) in the malignancy group. In patients below age 40 malignancy was never responsible for the hypercalcemia, but in patients over 50 malignancy was present in 65%. Of the patients with solid tumors 54.8% had skeletal metastases, while other organ metastases were found in 33.3% of these. The occurrence of a hypercalcemia in patients with malignancy is associated with a poor prognosis since over 60% of the patients died within as little as 1 mo. and > 90% within a year after the occurrence of hypercalcemia. Renal function impairment in hypercalcemia was significantly more marked in the patients with malignancy than in patients with p.Hp. and was closely related to the Ca levels. Pharmacological reduction of the blood Ca level produced a distinct improvement in renal function in 70% of the patients treated. The current hypothesis on the pathogenesis of hypercalcemia among carcinoma patients is discussed.

This publication has 0 references indexed in Scilit: